Australia's Rhinomed hits near 8-week high on upbeat quarterly revenue
** Shares of Rhinomed Ltd RNO.AX jump as much as 15.4% to
A$0.30, set to gain most since Dec 1
** Medical device maker says its second-quarter revenue rose
17% to A$2.03 mln ($1.45 million) urn:newsml:reuters.com:*:nFWN2U41PY
** Co says quarterly cash receipts from customers rose 63%
to A$2.5 mln
** As of last close, stock down 16.1% this year
($1 = 1.4000 Australian dollars)
(Reporting by Navya Mittal)
((Navya.Mittal@thomsonreuters.com;))
Recent news on Rhinomed
See all newsBrief: Rhinomed Says Q2 Revenues Of A$1.8M
Australia's Rhinomed hits record low after delisting and capital raise announcement
Brief: Rhinomed Formally Applies To ASX Requesting Removal From Official List
Brief: Rhinomed Ltd Seeks Trading Halt
Brief: Rhinomed Says It Is Implementing Measures To Reduce Cash Burn, Including Reduction In Headcount